Association between a nurse-led advocacy model and treatment adherence among patients with pulmonary Tuberculosis: a non-randomized controlled trial in Zhejiang Province, China

Background Systemic barriers and patient-centered monitoring deficits often undermine tuberculosis (TB) treatment adherence in urban environments, escalating the risk of clinical attrition and multidrug resistance. This study evaluated the association between an integrated Nurse-Led Advocacy Model (NLAM) and therapeutic adherence among patients with pulmonary TB within Zhejiang Province, China.Methods A non-randomized controlled trial was conducted across municipal clinics in Shaoxing, Zhejiang, between August 17, 2023, to August 1, 2025. Following propensity score matching via a 1:1 nearest-neighbor algorithm to eliminate baseline imbalances, 300 patients were evaluated: 152 in the NLAM cohort (received structured, face-to-face advocacy sessions spanning intensive and continuation phases with digital adherence technology (DAT) consisting of an electronic smart pill box and the WeChat-TB mini-program interface and 148 in the routine clinical care (RCC cohort; received standard institutional treatment monitoring).Results Baseline demographic profiles and clinical characteristics were highly balanced between groups (p > 0.05). The NLAM cohort exhibited significantly higher medication adherence across both drug-susceptible (mean ± SD: 94.5% ± 2.6% vs. 82.8% ± 2.9%; p < 0.001) and multidrug-resistant strains (90.9% ± 2.1% vs. 72.3% ± 2.1%; p < 0.001) compared to the RCC group. Longitudinal survival analysis showed a significantly lower rate of cumulative clinical attrition under the advocacy framework (5.3% [8/152] vs. 14.9% [22/148] loss to follow-up events; Relative Risk = 0.35, 95% Confidence Interval: 0.16–0.77; Log-rank p < 0.001). Patient-perceived nursing support based on the Nursing Advocacy Scale was remarkably higher in the NLAM cohort (p < 0.001).Conclusion Structured nurse-led advocacy framework coupled with smart-box digital monitoring is strongly associated with optimized medication adherence, heightened patient-perceived support, and minimized clinical attrition.

Authors

Institutions

Publication Details

Journal
Annals of Medicine
Published
2026-11-18
DOI
https://doi.org/10.1080/07853890.2026.2756147
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between a nurse-led advocacy model and treatment adherence among patients with pulmonary Tuberculosis: a non-randomized controlled trial in Zhejiang Province, China

柯尊友, Yinna Yao, Jianying Cai, Weiwei Chen
Annals of Medicine
Tuberculosis Research and Epidemiology
article

Association between a nurse-led advocacy model and treatment adherence among patients with pulmonary Tuberculosis: a non-randomized controlled trial in Zhejiang Province, China

柯尊友, Yinna Yao, Jianying Cai, Weiwei Chen
article en

Abstract

Background Systemic barriers and patient-centered monitoring deficits often undermine tuberculosis (TB) treatment adherence in urban environments, escalating the risk of clinical attrition and multidrug resistance. This study evaluated the association between an integrated Nurse-Led Advocacy Model (NLAM) and therapeutic adherence among patients with pulmonary TB within Zhejiang Province, China.Methods A non-randomized controlled trial was conducted across municipal clinics in Shaoxing, Zhejiang, between August 17, 2023, to August 1, 2025. Following propensity score matching via a 1:1 nearest-neighbor algorithm to eliminate baseline imbalances, 300 patients were evaluated: 152 in the NLAM cohort (received structured, face-to-face advocacy sessions spanning intensive and continuation phases with digital adherence technology (DAT) consisting of an electronic smart pill box and the WeChat-TB mini-program interface and 148 in the routine clinical care (RCC cohort; received standard institutional treatment monitoring).Results Baseline demographic profiles and clinical characteristics were highly balanced between groups (p > 0.05). The NLAM cohort exhibited significantly higher medication adherence across both drug-susceptible (mean ± SD: 94.5% ± 2.6% vs. 82.8% ± 2.9%; p < 0.001) and multidrug-resistant strains (90.9% ± 2.1% vs. 72.3% ± 2.1%; p < 0.001) compared to the RCC group. Longitudinal survival analysis showed a significantly lower rate of cumulative clinical attrition under the advocacy framework (5.3% [8/152] vs. 14.9% [22/148] loss to follow-up events; Relative Risk = 0.35, 95% Confidence Interval: 0.16–0.77; Log-rank p < 0.001). Patient-perceived nursing support based on the Nursing Advocacy Scale was remarkably higher in the NLAM cohort (p < 0.001).Conclusion Structured nurse-led advocacy framework coupled with smart-box digital monitoring is strongly associated with optimized medication adherence, heightened patient-perceived support, and minimized clinical attrition.

Annals of MedicineVol. 58(1)
Shaoxing University (CN), Shaoxing People's Hospital (CN)
Shaoxing University
Good health and well-being
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon